Regarding the association of abnormal PAD-related values with future AAV poor outcomes, among the three methods for identifying subclinical but substantial PAD, only patients with abnormal SPP exhibited a significantly lower cumulative ESKD-free survival rate than those with normal SPP (p = 0.046) (Figure 2). This evidence concerns the gene HM13 and peripheral arterial disease.